Literature DB >> 20332575

Comparison of ethidium monoazide and propidium monoazide for the selective detection of viable Legionella cells.

Bin Chang1, Toshitsugu Taguri, Kanji Sugiyama, Junko Amemura-Maekawa, Fumiaki Kura, Haruo Watanabe.   

Abstract

Ethidium monoazide (EMA) and propidium monoazide (PMA) have been utilized for selective PCR amplification of DNA from viable bacterial cells. In this study, we compared the abilities of EMA and PMA, together with real-time PCR, to specifically distinguish dead Legionella cells from viable cells. Several experiments showed that PMA or EMA treatment could specifically prevent the PCR amplification of DNA from dead Legionella cells in water samples. However, a 4-fold higher concentration of PMA than EMA was required to achieve this effect. EMA may therefore be more useful for practical environmental investigations of Legionella.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332575

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  18 in total

1.  Viability Quantitative PCR Utilizing Propidium Monoazide, Spheroplast Formation, and Campylobacter coli as a Bacterial Model.

Authors:  Thomai P Lazou; Eleni G Iossifidou; Athanasios I Gelasakis; Serafeim C Chaintoutis; Chrysostomos I Dovas
Journal:  Appl Environ Microbiol       Date:  2019-10-01       Impact factor: 4.792

2.  On-filter direct amplification of Legionella pneumophila for rapid assessment of its abundance and viability.

Authors:  Farag A Samhan; Tiffany M Stedtfeld; Hassan Waseem; Maggie R Williams; Robert D Stedtfeld; Syed A Hashsham
Journal:  Water Res       Date:  2017-05-13       Impact factor: 11.236

3.  Application of EMA-qPCR as a complementary tool for the detection and monitoring of Legionella in different water systems.

Authors:  Tian Qin; Zhengan Tian; Hongyu Ren; Guangchun Hu; Haijian Zhou; Jinxing Lu; Chengwang Luo; Zunyu Liu; Zhujun Shao
Journal:  World J Microbiol Biotechnol       Date:  2012-01-05       Impact factor: 3.312

4.  Comparative analysis and limitations of ethidium monoazide and propidium monoazide treatments for the differentiation of viable and nonviable campylobacter cells.

Authors:  Diana Seinige; Carsten Krischek; Günter Klein; Corinna Kehrenberg
Journal:  Appl Environ Microbiol       Date:  2014-01-31       Impact factor: 4.792

5.  Viable real-time PCR in environmental samples: can all data be interpreted directly?

Authors:  Mariana Fittipaldi; Francesc Codony; Barbara Adrados; Anne K Camper; Jordi Morató
Journal:  Microb Ecol       Date:  2010-07-15       Impact factor: 4.552

6.  Detection and Quantification of Viable and Nonviable Trypanosoma cruzi Parasites by a Propidium Monoazide Real-Time Polymerase Chain Reaction Assay.

Authors:  Beatriz Cancino-Faure; Roser Fisa; M Magdalena Alcover; Teresa Jimenez-Marco; Cristina Riera
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

7.  Experimental design for the optimization of propidium monoazide treatment to quantify viable and non-viable bacteria in piggery effluents.

Authors:  Jérémy Desneux; Marianne Chemaly; Anne-Marie Pourcher
Journal:  BMC Microbiol       Date:  2015-08-16       Impact factor: 3.605

8.  Detection of viable plasmodium ookinetes in the midguts of anopheles coluzzi using PMA-qrtPCR.

Authors:  Tibebu Habtewold; Zoe Groom; Luc Duchateau; George K Christophides
Journal:  Parasit Vectors       Date:  2015-09-15       Impact factor: 3.876

9.  Propidium monoazide-polymerase chain reaction for detection of residual periprosthetic joint infection in two-stage revision.

Authors:  Mohamed Askar; Mariam Sajid; Yassar Nassif; Waheed Ashraf; Brigitte Scammell; Roger Bayston
Journal:  Mol Biol Rep       Date:  2019-10-05       Impact factor: 2.316

10.  Method to quantify live and dead cells in multi-species oral biofilm by real-time PCR with propidium monoazide.

Authors:  Gerard Alvarez; Marta González; Sergio Isabal; Vanessa Blanc; Rubén León
Journal:  AMB Express       Date:  2013-01-04       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.